IL100550A - Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleic acid analogue and the history of a reductase inhibitory ribomocalotide peptide - Google Patents

Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleic acid analogue and the history of a reductase inhibitory ribomocalotide peptide

Info

Publication number
IL100550A
IL100550A IL10055091A IL10055091A IL100550A IL 100550 A IL100550 A IL 100550A IL 10055091 A IL10055091 A IL 10055091A IL 10055091 A IL10055091 A IL 10055091A IL 100550 A IL100550 A IL 100550A
Authority
IL
Israel
Prior art keywords
peptide
formula
asp
acceptable salt
therapeutically acceptable
Prior art date
Application number
IL10055091A
Other languages
English (en)
Hebrew (he)
Other versions
IL100550A0 (en
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of IL100550A0 publication Critical patent/IL100550A0/xx
Publication of IL100550A publication Critical patent/IL100550A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
IL10055091A 1990-12-31 1991-12-30 Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleic acid analogue and the history of a reductase inhibitory ribomocalotide peptide IL100550A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002033447A CA2033447C (en) 1990-12-31 1990-12-31 Synergistic combination for treating herpes infections

Publications (2)

Publication Number Publication Date
IL100550A0 IL100550A0 (en) 1992-09-06
IL100550A true IL100550A (en) 1995-11-27

Family

ID=4146736

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10055091A IL100550A (en) 1990-12-31 1991-12-30 Anti-herpes pharmaceuticals and cosmetics containing a combination of an antiviral nucleic acid analogue and the history of a reductase inhibitory ribomocalotide peptide

Country Status (9)

Country Link
US (1) US5380727A (de)
EP (1) EP0493767B1 (de)
JP (1) JP3209553B2 (de)
AT (1) ATE150317T1 (de)
AU (1) AU648854B2 (de)
CA (1) CA2033447C (de)
DE (1) DE69125262T2 (de)
IL (1) IL100550A (de)
NZ (1) NZ241120A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives
JP4110347B2 (ja) * 1999-11-05 2008-07-02 大鵬薬品工業株式会社 抗ｈｉｖ剤
CA2399676C (en) 2000-02-07 2010-04-06 Wisconsin Alumni Research Foundation Pharmacologically active antiviral peptides and methods of their use
US7432045B2 (en) * 2003-12-01 2008-10-07 Wisconsin Alumni Research Foundation Method of inhibiting influenza infection with antiviral peptides
US9376438B2 (en) 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
SI2710005T1 (sl) 2011-05-17 2017-03-31 Principia Biopharma Inc. Zaviralci tirozinske kinaze
MX361815B (es) 2012-09-10 2018-12-17 Principia Biopharma Inc Compuestos pirazolopirimidinicos como inhibidores de cinasas.
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
KR20220027271A (ko) 2014-02-21 2022-03-07 프린시피아 바이오파마, 인코퍼레이티드 Btk 억제제의 염 및 고체 형태
WO2016100914A1 (en) 2014-12-18 2016-06-23 Gourlay Steven Treatment of pemphigus
TW201718572A (zh) 2015-06-24 2017-06-01 普林斯匹亞生物製藥公司 酪胺酸激酶抑制劑
IL293621B2 (en) 2016-06-29 2023-09-01 Principia Biopharma Inc Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(oxane-3-yl)piperazine-1-yl)penta-2-ananitrile
JP6510578B2 (ja) 2017-03-28 2019-05-08 本田技研工業株式会社 ヘッドアップディスプレイ装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor

Also Published As

Publication number Publication date
NZ241120A (en) 1994-02-25
EP0493767B1 (de) 1997-03-19
ATE150317T1 (de) 1997-04-15
AU9009191A (en) 1992-07-02
EP0493767A3 (en) 1993-03-17
US5380727A (en) 1995-01-10
IL100550A0 (en) 1992-09-06
DE69125262D1 (de) 1997-04-24
JPH04275230A (ja) 1992-09-30
CA2033447C (en) 1999-08-31
EP0493767A2 (de) 1992-07-08
AU648854B2 (en) 1994-05-05
DE69125262T2 (de) 1997-10-09
JP3209553B2 (ja) 2001-09-17
CA2033447A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
US5380727A (en) Synergistic combination for treating herpes infections
US5484771A (en) Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
CA2033448C (en) Antiherpes compositions and method of use
EP0560267B1 (de) Isosterische Peptidderivate gegen Herpes
AU683450B2 (en) Inhibitors of herpes viral ribonucleotide reductase
AU683465B2 (en) Method of combating acyclovir-resistant herpes simplex viral infections
EP0560274B1 (de) Peptidderivate mit einem Ureido-N-Terminus gegen Herpes
US5830864A (en) Antiherpes peptide derivatives having a ureido n-terminus
US5574015A (en) Isosteric antiherpes peptide derivatives

Legal Events

Date Code Title Description
FF Patent granted
HP Change in proprietorship
KB Patent renewed
RH Patent void
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees